ME/CFS diagnostikatzeko, sintoma-eredu bereizgarri bat eta funtzionamendu murriztua hartzen dira kontuan, ez odol-analisi positibo bat. Ebaluazioan, sintoma horiek azal edo lagun ditzaketen gaixotasun tratagarriak ere aztertzen dira.
- Diagnostiko klinikoa sintoma-eredu bereizgarri bat behar du; ohiko odol-analisi batek ez du ME/CFS baieztatzen edo baztertzen.
- Esfortzuaren ondorengo ondoeza jarduera egin eta 12–48 ordura hasi ohi da eta egun batzuk edo gehiago iraun dezake; ariketa egin ondorengo ohiko nekea bestelakoa da.
- AEBetako diagnostiko-irizpideek 6 hilabete baino gehiago irauten duen narriadura nabarmena, nekea, PEM, lo ez-berritzailea eta narriadura kognitiboa edo intolerantzia ortostatikoa eskatzen dituzte.
- Erresuma Batuko NICE irizpideek 3 hilabeteren ondoren diagnostikoa egitea ahalbidetzen dute, 4 sintoma-talde nagusiak agertzen badira eta beste gaixotasun batek azaltzen ez baditu.
- Sintomen maiztasuna National Academy of Medicine esparruaren arabera, denboraren erdian gutxienez agertu behar luke, eta intentsitate moderatukoa edo handiagokoa izan.
- Burdin-gabezia anemia agertu aurretik nekea eragin dezake; 15 ng/mL-tik beherako ferritinak biltegiak agortuta daudela adierazten du argi eta garbi, bestela osasuntsu dauden helduetan.
- Ebaluazio ortostatikoa gainbegiratutako zutik egotea 10 minutuz ere har dezake; POTS diagnostikatzeko ez da nahikoa pultsu-maiztasun handiko neurketa bakarra.
- Hurrengo urratsak energiaren kudeaketa, batera dauden gaitzen tratamendua eta jarraipen planifikatua barne hartzen dituzte, ez ariketa-maila astero nahitaez handitzea.
Nola diagnostikatzen da ME/CFS kontsulta kliniko batean?
Neke kronikoaren sindromearen diagnostikoa klinikoa da: klinikariek esfortzuaren ondorengo ondoeza, eguneroko funtzionamenduaren galera nabarmena, lo ez-berritzailea eta sintoma kognitiboak edo ortostatikoak identifikatzen dituzte, eta, ondoren, bestelako azalpenak aztertzen dituzte. Ez dago ME/CFS baieztatzen duen ohiko odol-analisirik. National Academy of Medicine-ren esparruak 6 hilabete baino gehiagoko narriadura eskatzen du; Erresuma Batuko NICEk, berriz, 3 hilabeteren ondoren baimentzen du diagnostikoa.
Ebaluazioak bi ildo paralelo ditu: ME/CFS eredua dagoen zehaztea eta bestelako kausa sinesgarriak ikertzea. Panel normal batek ez du berez bi ildo horietako bat ere osatzen; era berean, laborategiko anomalia txiki bat aurkitzeak ez ditu automatikoki azaltzen funtzionamenduaren gainbehera larria edo ohiko jardueraren ondorengo sintoma-atzeraldiak.
Lehen hitzordu baliagarri batean hiru erreferentzia jasotzen dira: gaixotu aurretik zer egin zenezakeen, orain zer egin dezakezun eta ondoren zer gertatzen den. Laneko txanda bat egiten jarraitzen duen pertsona batek narriadura nabarmena izan dezake hala ere, lanak bere ahalmen erabilgarri guztia kontsumitzen badu eta janaria prestatzeko, dutxatzeko edo familia-bizitzan parte hartzeko ezintasunean uzten badu.
Thomas Klein naiz, MD, Kantestiko mediku-zuzendaria, eta funtzionamenduari buruzko galdera horietatik hasiko nintzateke, denetariko panel bat eskatu beharrean. Gure erakundea eta helburua laborategiko informazioa interpretatzearen eta historia klinikoa, azterketa eta, batzuetan, hainbat hitzordu eskatzen dituen diagnostikoa egitearen arteko aldea azaltzen dute.
Kantesti bat da. AI odol-analisi analizatzailea nekea eragiten duten bestelako kausak ikertzeko emaitzak azaltzen lagun dezake, baina ezin du eskatutako sintoma-eredua ezarri. 2026ko urriaren 23an, gida honek NICEren 2021eko gidalerroa eta National Academy of Medicine-ren 2015eko esparrua ditu oinarri, ez 2026an ustez sortutako diagnostikorako odol-analisi berri bat.
Zein dira National Academy of Medicine erakundearen diagnostiko-irizpideak?
The National Academy of Medicine-ren 2015eko irizpideak gaixotasuna hasi aurreko jardueraren murrizketa nabarmena eskatzen dute, 6 hilabete baino gehiago irauten duena, nekearekin, esfortzuaren ondorengo ondoezarekin eta lo ez-berritzailearekin batera. Gutxienez ezaugarri osagarri bat behar da: narriadura kognitiboa edo intolerantzia ortostatikoa. Sintomek denboraren erdian gutxienez agertu behar dute, intentsitate ertain, nabarmen edo larriarekin.
Nekeak agerpen berrikoa edo argi eta garbia izan behar du, ez bizitza osokoa, ez etengabeko gehiegizko esfortzuaren ondorioa, eta atsedenarekin ez da nabarmen arindu behar. Zehaztapen horiek sindromea hilabete bereziki zorrotz baten ondoren agortuta sentitzea baino gehiago dela bereizten dute; 6 hilabeteko baldintzak ez du esan nahi epe hori bete arte arreta ukatu behar denik.
National Academy of Medicine-ren txostenak, Institute of Medicine izenarekin argitaratuak, sintomen maiztasuna eta larritasuna azpimarratzen ditu, noizbehinkako esperientzien kontrol-zerrenda bat baino gehiago (Institute of Medicine, 2015). Gau txar bat izatea eta noizean behin ahaztea ez dira ohiko aste batean zehar berriz agertzen diren eta funtzionamendua mugatzen duten sintomen parekoak.
Demagun heldu baten adibide argigarri bat: ordaindutako lanorduak astean 40tik 20ra murriztu ditu, bileren ondoren sintomak okertzen zaizkio atzerapenez, eta freskatu gabe esnatzen da, lo egiteko aukera nahikoa izan arren. Pentsamenduaren moteltzeak sintoma-eremu osagarria bete lezake; zutik jartzean zorabioa izateak ebaluazioa indartuko luke, baina ez da nahitaezkoa esparru honen arabera.
A hasierako laborategiko ebaluazio baliagarria bestelako azalpenen bilaketa laguntzen du; ez ditu baldintza kliniko horiek ordezten. Ekarri botiken zerrenda bat eta sintomen maiztasunari buruzko laburpen bat, 2 aste adierazgarritan oinarritua; sartu, halaber, atzeraldi bat saihesteko nahita oso gutxi egin zenuen egunak.
Zergatik dira desberdinak Erresuma Batuko eta AEBetako diagnostiko-epeak?
NICE NG206 gidalerroak 3 hilabeteren ondoren ME/CFS diagnostikatzea baimentzen du sintomek irauten badute eta beste gaitz batek azaltzen ez baditu; National Academy of Medicine-ren esparruak, berriz, jardueraren narriadura 6 hilabete baino gehiagoz izatea eskatzen du. NICEk oinarrizko lau sintoma-multzoak eskatzen ditu, zailtasun kognitiboak barne; AEBetako esparruak, aldiz, narriadura kognitiboa edo intolerantzia ortostatikoa onartzen ditu.
NICEk ME/CFS susmatzea aholkatzen du sintomek helduetan gutxienez 6 astez edo haur eta gazteengan 4 astez iraun badute, eredu bereizgarria eta funtzionamendu murriztua badaude (NICE, 2021). Susmoak ikerketa eta laguntza abiarazten ditu; ez da diagnostiko baieztatu baten parekoa, ezta bestelako aukerak aztertzeari uzteko arrazoia ere.
3 hilabeteko eta 6 hilabete baino gehiagoko atalaseak gidalerroetako muga operatiboak dira, ez data jakin batean etengailu biologiko bat pizten denaren froga. Klinikariak erabili duen esparrua jaso beharko luke, geroko espezialista batek, aseguratzaile batek edo ikastetxe batek uler dezan zergatik egin zen diagnostikoa eta zein sintoma erregistratu ziren.
Children need an assessment of attendance, learning, social participation, and basic daily activities—not merely an adult questionnaire scaled down. A child attending school for 2 mornings weekly may appear outwardly engaged while needing prolonged recovery afterward; parents’ observations and the child’s own account can reveal different parts of the pattern.
Gure azalpenak pediatric interpretation limits addresses why age-specific laboratory ranges require care, but laboratory interpretation cannot replace pediatric assessment. Support at school and advice about avoiding symptom-provoking overexertion can begin during the initial 4-week or 6-week suspicion period, before diagnostic confirmation.
Nola hautematen dute klinikariek esfortzuaren ondorengo ondoeza?
Post-exertional malaise, or PEM, is worsening of the illness after activity that previously would have been tolerated. Physical, cognitive, emotional, or social exertion can trigger it. Symptoms often worsen 12–48 hours later and may persist for days or longer, although onset and recovery vary considerably between patients.
PEM is more than muscle soreness or being pleasantly tired after exercise. A 20-minute conversation might be followed by intensified cognitive problems, sleep disturbance, pain, flu-like feelings, or reduced upright tolerance; the diagnostic clue is a disproportionate, multisymptom deterioration rather than the fact that activity used energy.
Ask about the day after the day after. A patient may feel reasonably capable during a supermarket trip yet spend the next 2 days recovering, so asking only whether they can shop misses the cost; repeated activity can also produce overlapping crashes that obscure any single trigger.
A 7–14-day activity-and-symptom diary can document the pattern without deliberately provoking it. Record the type of activity, approximate duration, immediate response, next-day response, and recovery time; our timeline interpretation guide explains a separate issue—why laboratory changes also need context rather than attribution to one event.
Two-day cardiopulmonary exercise testing is not required for routine ME/CFS diagnosis and can provoke substantial symptom worsening. It may have a role in selected specialist or disability assessments, but a clinician should discuss risks, practical benefit, and alternatives; a patient does not need to demonstrate a crash by pushing through a test.
Zer jotzen da eguneroko funtzionamenduaren narriadura nabarmen gisa?
Substantial impairment means a sustained reduction from the person’s own pre-illness capacity, not failure to meet an arbitrary step count. Clinicians assess work, education, personal care, household activity, and social participation. There is no universally required 50% reduction threshold in the National Academy of Medicine or NICE diagnostic framework.
Compare like with like over 2 periods: before illness and a representative current week. A former full-time worker managing 10 hours weekly has an obvious decline, but a caregiver maintaining essential tasks by abandoning leisure, relying on help, and resting between chores may have impairment that employment statistics completely miss.
Activity counts can underestimate illness when patients have already adapted successfully. Someone taking 3,000 steps daily without a conspicuous crash may be staying within a restricted energy limit; the absence of recent PEM during strict pacing does not establish that the underlying exertional intolerance has disappeared.
Clinicians also separate fatigue from weakness, breathlessness, and sleepiness because these suggest different investigations. Difficulty lifting a cup, falling asleep involuntarily, and feeling depleted after a shower are 3 different descriptions; asking the patient to demonstrate or describe the limitation can prevent an unhelpfully broad label of tiredness.
Treatable contributors still deserve attention when the ME/CFS pattern is convincing. For example, iron depletion before anemia can add to limited capacity, particularly with heavy menstrual loss; improvement after correcting low iron does not necessarily eliminate a separate pattern of delayed PEM and unrefreshing sleep.
Nola ebaluatzen da lo ez-berritzailea, loaren nahasmendurik ez uzteko?
Unrefreshing sleep means waking without expected restoration, even when sleep opportunity appears adequate. It is required by both major ME/CFS frameworks, but it does not exclude obstructive sleep apnea, insomnia, restless legs syndrome, or another sleep disorder. Sleeping 8–9 hours is not proof that sleep quality is normal.
A sleep history should cover bedtime, wake time, awakenings, snoring, witnessed breathing pauses, restless legs, and daytime sleep attacks. A 2-week sleep diary often clarifies whether the problem is insufficient opportunity, disrupted sleep, an irregular rhythm, or a persistent lack of restoration despite a reasonably consistent schedule.
Sleepiness and fatigue overlap, but they are not interchangeable. Someone who unintentionally falls asleep during a 15-minute quiet activity needs assessment for excessive daytime sleepiness; someone who remains awake but feels cognitively and physically depleted may need a different pathway, although both problems can occur together.
Gure sleep-study diagnostic pathway explains why narcolepsy testing requires careful preparation and specialist interpretation. Neither a normal overnight study nor a normal multiple sleep latency test rules out ME/CFS; these tests answer questions about sleep physiology, not the entire clinical syndrome.
Treat an identified sleep disorder and reassess the remaining symptom pattern rather than assuming 1 diagnosis explains everything. If effective apnea treatment improves alertness but a short outing still triggers a 48-hour multisymptom deterioration, the clinician should continue evaluating PEM and function instead of declaring the fatigue assessment finished.
Zein sintoma kognitibok laguntzen dute ME/CFS diagnostikatzen?
ME/CFS cognitive symptoms can include slowed processing, reduced attention, word-finding problems, and difficulty holding information in mind. They may worsen after exertion or while upright. New cognitive difficulties occurring alongside PEM differ from lifelong attention problems; a normal brief screening score does not necessarily capture fluctuating impairment.
Ask for 2 concrete examples rather than accepting brain fog as a complete description. Losing track of a familiar recipe and needing repeated rereading of a short email reveal different limitations; examples also help clinicians distinguish processing difficulty from a language deficit, severe sleepiness, medication effects, or progressive neurological disease.
The conditions of testing matter. A 10-minute assessment in a quiet room after rest may look normal despite major difficulties during a noisy workday; clinicians can document this mismatch without asserting that every complaint requires formal neuropsychological testing or that a normal test means the symptoms are imagined.
Lifelong distractibility requires a developmental history, whereas new slowing after illness requires assessment of onset and associated symptoms. Our discussion of lifelong attention versus brain fog explains why 1 adult screening questionnaire cannot reliably resolve that distinction or establish the cause of a recent decline.
Sudden speech disturbance, new one-sided weakness, or acute confusion requires urgent assessment rather than attribution to ME/CFS. Gradual but progressive deterioration over 3–6 months also warrants reconsideration of alternatives; familiar brain fog should not become a catch-all explanation for a genuinely new neurological symptom.
Nola ebaluatzen dira intolerantzia ortostatikoa eta POTS?
Orthostatic intolerance causes symptoms while upright that improve with sitting or lying down, such as lightheadedness, palpitations, nausea, or cognitive worsening. Clinicians may measure pulse and blood pressure during a supervised stand lasting up to 10 minutes. POTS is one possible diagnosis, not a requirement for ME/CFS.
Adult POTS criteria include a sustained heart-rate rise of at least 30 beats/minute within 10 minutes upright; the threshold is at least 40 beats/minute for ages 12–19. The diagnosis also requires frequent orthostatic symptoms for at least 3 months, no significant orthostatic hypotension, and no other explanation for the tachycardia (Raj et al., 2022).
A blood-pressure fall of at least 20 mmHg systolic or 10 mmHg diastolic within 3 minutes of standing suggests classic orthostatic hypotension. These thresholds describe different physiological patterns; a single smartwatch pulse spike cannot determine which pattern is present or whether medication, dehydration, anemia, or thyroid disease is responsible.
Morning testing may reveal a stronger heart-rate response, and results can vary between visits. If a 10-minute stand is intolerable, stop and adapt the assessment rather than insisting on completion; people with severe ME/CFS may need shorter measurements, specialist advice, or home-based arrangements that minimize symptom worsening.
Gure palpitation assessment guide covers laboratory contributors, but an ECG and clinical examination may also be needed. Salt, fluid, compression, or medication advice should be individualized; a blanket instruction to drink 3 liters daily is inappropriate for someone with heart failure, kidney disease, or fluid restrictions.
Zergatik ezin du ohiko odol-analisi batek ME/CFS baieztatu?
No routine blood test has established diagnostic accuracy sufficient to confirm or rule out ME/CFS. Normal full blood count, thyroid function, ferritin, or inflammatory markers do not exclude it. Research findings in immune function, metabolism, and other systems are not interchangeable with a validated test for an individual patient.
A useful diagnostic biomarker must distinguish the target condition from realistic alternatives, not merely separate 2 small groups of patients and healthy volunteers. It also needs reproducible performance across laboratories and populations; an intriguing research signal may fail when compared with sleep disorders, long COVID, autoimmune disease, or medication-related fatigue.
Sensitivity and specificity depend on the intended use and the population tested. Even an apparently promising 90% specificity can create many false positives when used in a low-prevalence population; without independently validated clinical performance, a commercial score should not replace documented PEM, functional decline, and a proper differential assessment.
Kantesti bat da. AI odol-analisien interpretazio-plataforma that explains laboratory findings; it does not turn normal results into a positive ME/CFS diagnosis. Our estandar teknikoak eta klinikoak should be considered separately from disease-specific validation: interpreting a thyroid result accurately is not evidence that an engine can diagnose ME/CFS.
Repeatedly ordering the same normal panel every 4 weeks rarely resolves an unchanged clinical question. Retesting becomes more useful when symptoms change, an abnormality needs follow-up, a treatment could affect results, or a new examination finding raises a different hypothesis; otherwise, the next step may be better history-taking rather than more samples.
Zein oinarrizko analisik laguntzen dute nekearen beste kausa batzuk ebaluatzen?
Baseline investigations look for alternative or accompanying conditions—not an ME/CFS signature. NICE lists full blood count, kidney and liver tests, thyroid function, ESR or plasma viscosity, CRP, calcium, phosphate, HbA1c, ferritin, celiac screening, creatine kinase, and urinalysis. Additional tests, including B12, folate, vitamin D, or 9 a.m. cortisol, depend on clinical judgment.
Ferritin below 15 ng/mL strongly supports depleted iron stores in otherwise healthy adults, but inflammation can raise ferritin and conceal deficiency. The iron-study interpretation guide explains why transferrin saturation and clinical context may be needed; one result should not be treated as a universal threshold for every patient.
Thyroid interpretation usually begins with TSH, with free T4 added or interpreted according to the clinical situation. A mildly high TSH with normal free T4 does not automatically explain severe PEM; our tiroxinari eta TSHri buruzko azalpenak helps distinguish overt dysfunction from a result that may require repeat testing.
B12 assessment becomes particularly relevant with dietary restriction, malabsorption risk, neuropathic symptoms, or macrocytosis; neurological deficiency can occur without anemia. A total B12 of 200–300 pg/mL may be considered borderline in some laboratories, and our B12 marjinalaren jarraipen-gida explains why assay ranges and confirmatory testing matter.
Kantesti can help organize these results alongside their units, laboratory intervals, and previous values, but the ordering clinician decides what is appropriate. Tell them about supplements, recent illness, and medications before the appointment; a 9 a.m. cortisol, for example, addresses selected adrenal concerns and is not a general test for stress or an ME/CFS confirmation test.
Nola erabakitzen dute klinikariek beste diagnostiko batek sintomak azaltzen dituen?
Alternative diagnoses are assessed through history, examination, and targeted investigations, with attention to whether they explain the whole symptom pattern. Anemia, thyroid disease, sleep disorders, medication effects, cardiopulmonary disease, autoimmune conditions, and depression can cause fatigue. More than 1 diagnosis may be present, so finding a contributor does not automatically exclude ME/CFS.
A medication review should include prescriptions, over-the-counter products, supplements, alcohol, and other substances, with changes over the preceding 3 months. Sedating antihistamines, some pain medicines, and other drugs may impair alertness; beta-blockers can change pulse responses, complicating interpretation of an upright assessment without necessarily explaining delayed PEM.
Autoimmune testing becomes more useful when fatigue accompanies specific findings such as persistent joint swelling, photosensitive rash, Raynaud symptoms, or marked dryness. Our dryness and systemic symptom guide explains one relevant pathway; fatigue alone generally provides a weaker reason for broad antibody screening than fatigue plus 2 objective or characteristic features.
Depression deserves respectful assessment and treatment when present, but it should not be inferred from reduced activity alone. A person who wants to participate but develops a 2-day crash afterward presents a different clinical question from reduced motivation; mood symptoms and ME/CFS can coexist, and neither should erase the other.
New weight loss, persistent fever, abnormal examination findings, or progressive objective weakness shifts the differential away from uncomplicated fatigue. Ask whether an alternative explains 3 elements together—onset, symptom pattern, and trajectory—then reassess after appropriate treatment rather than assuming that a borderline laboratory result has settled the diagnosis.
Noiz dira lagungarriak infekzioen eta antigorputz autoimmunitarioen analisiak?
Infection and autoimmune tests help when exposure history, examination, or specific symptoms justify them. They do not confirm ME/CFS simply because they are positive. EBV IgG commonly reflects previous infection, while a positive ANA can occur without systemic autoimmune disease; interpretation requires the antibody pattern and the clinical question.
EBV antibody testing distinguishes patterns of exposure; it is not a meter of ongoing fatigue severity. Our EBV antigorputz-ereduen gida explains VCA IgM, VCA IgG, and EBNA; more than 90% of adults have evidence of previous EBV infection, so a positive IgG alone is unsurprising.
ANA interpretation depends on method, titer, pattern, and compatible clinical findings. A result such as 1:80 does not establish lupus or explain PEM by itself; the ANA interpretation basics explain why a screening result may require no additional testing in one patient but targeted evaluation in another.
Long COVID and ME/CFS can overlap, particularly when delayed exertional worsening, unrefreshing sleep, and cognitive or orthostatic symptoms persist. Not everyone with long COVID meets ME/CFS criteria, and someone with 3 months of post-COVID symptoms may meet NICE’s timeline before meeting the National Academy of Medicine duration requirement.
Broad panels for multiple pathogens can create false leads when exposure risk is low and positive antibodies merely show past contact. Targeted testing should answer a specific question—such as a compatible illness after a tick exposure—rather than search for any positive result that might justify months of antimicrobial treatment without evidence of active infection.
Zer egin behar da ME/CFS susmatzen edo diagnostikatzen denean?
Next steps include individualized energy management, treatment of accompanying conditions, and planned reassessment. Support should begin before every diagnostic uncertainty is resolved. NICE advises against programs using fixed incremental increases in activity or exercise, including graded exercise therapy; the goal is to avoid provoking PEM, not meet a predetermined weekly exercise target.
Energy management includes physical, cognitive, emotional, and social activity—not just steps or workouts. Splitting a 20-minute task into shorter parts may help, but there is no universal safe interval; decisions should follow the patient’s response, including symptoms appearing the following day rather than only during the task.
A practical follow-up plan names 3 things: who coordinates care, which symptoms or results will be reassessed, and when to seek earlier help. Patients with severe or very severe ME/CFS may need home visits, reduced sensory stimulation, mobility support, and help accessing nutrition; attendance at a distant clinic can itself be a major exertional load.
Supplements should address a demonstrated need or a carefully discussed symptom goal, not a promise to cure ME/CFS. Our lab-guided fatigue supplement discussion separates deficiency treatment from unsupported combinations; adding 5 products at once also makes side effects and any benefit harder to interpret.
Chest pain, severe breathlessness, fainting with concerning features, sudden neurological symptoms, or inability to maintain fluids requires urgent assessment rather than waiting for a routine follow-up. A new decline over 24–48 hours should be judged on its features and severity; a previous ME/CFS diagnosis does not protect someone from an unrelated acute illness.
Zer leku du laborategiko emaitzen interpretazioak hurrengo urratseko arreta-planean?
Lab interpretation can support the search for treatable contributors, but a clinician remains responsible for ME/CFS diagnosis. A useful next-step packet contains 3 components: a symptom-and-function summary, relevant results with dates and units, and a medication list. It should make the appointment easier—not replace history-taking or examination.
Kantesti bat da. AI bidezko odol-analisien analisi-tresna that can explain uploaded laboratory reports and organize trends for discussion with a healthcare professional. Our AI teknologiaren azalpena describes the interpretation workflow; neither a report summary nor a risk score substitutes for documenting PEM and the applicable 3-month or more-than-6-month timeline.
Privacy matters when sharing a report that contains identifiers, dates of birth, or information about relatives. Review our pribatutasunari eta datuei buruzko informazioa before uploading, and share only information you are authorized to provide; keeping 1 concise, relevant record is often more useful than circulating an entire medical history.
My practical advice as Thomas Klein, MD, is to ask 3 questions: Which diagnostic framework applies, what alternatives still need assessment, and what support can start now? Information about our aholkularitza medikoko taldea provides organizational context, but your own clinician must assess your symptoms and arrange a workable follow-up plan.
The 2 repository guides listed below are related educational publications, not peer-reviewed validation of an ME/CFS biomarker. The complement-testing clinical context concerns selected autoimmune questions. The Nipah diagnostikorako hezkuntza-gida concerns a separate acute illness and is not a routine investigation for chronic fatigue.
Research publications and evidence boundaries
The 2 Zenodo records are presented as supplementary educational resources, separate from the directly relevant diagnostic references below. ResearchGate and Academia.edu links are title searches, not claims that verified copies exist on those services; neither repository publication supports diagnosing ME/CFS from routine laboratory results.
Maiz egiten diren galderak
Ba al dago neke kronikoaren sindromearen odol-analisirik?
Ez dago ME/CFS baieztatzen edo baztertzen duen ohiko odol-analisirik. Klinikoek sintoma-eredu bereizgarri batean, eguneroko funtzionamenduan izandako narriaduran eta bestelako azalpenen ebaluazioan oinarrituta diagnostikatzen dute gaitza. Medikuntzako Akademia Nazionalaren esparruak 6 hilabete baino gehiagoko narriadura eskatzen du; NICEk, berriz, 3 hilabeteren ondoren diagnostikatzea onartzen du. Odol-analisiek anemia, tiroide-gaixotasuna edo burdin eskasia bezalako faktore lagungarriak identifika ditzakete, baina emaitza normalek ez dute ME/CFS baztertzen.
Zein dira ME/CFS diagnostikatzeko irizpide nagusiak?
0 The National Academy of Medicine-ren irizpideek gaixotu aurreko jarduera-maila nabarmen murriztuta egotea 6 hilabete baino gehiagoz, nekea, esfortzuaren ondorengo ondoeza eta lo ez-indarberritzailea eskatzen dituzte. Narriadura kognitiboa edo intolerantzia ortostatikoa ere beharrezkoa da. Sintomek denboraren erdian gutxienez agertu behar dute, intentsitate moderatuarekin edo handiagoarekin. NICEk 3 hilabeteko diagnostiko-epea erabiltzen du, eta zailtasun kognitiboak eskatzen ditu, gainerako sintoma-multzo nagusiekin batera.
Nola jakin dezaket esfortzuaren ondorengo ondoezik dudan?
Esfortzuaren ondoko ondoezak sintomak neurriz kanpo okertzea dakar jarduera fisiko, kognitibo, emozional edo sozialaren ondoren. Okertzea 12–48 ordu geroago hasten da maiz, eta egunez edo gehiago iraun dezake, nahiz eta denbora aldatu egiten den. 7–14 eguneko jarduera- eta sintoma-egunkari batek klinikariari harremana identifikatzen lagun diezaioke, nahita krisialdirik eragin gabe. Ariketa arruntaren ondoko mina edo nekea, berez, ez da nahikoa PEM edo ME/CFS diagnostikoa ezartzeko.
ME/CFS diagnostika daiteke sei hilabete igaro aurretik?
NICE NG206ren arabera, ME/CFS diagnostikatu daiteke 3 hilabeteren ondoren, eskatutako sintoma-ereduak irauten badu eta beste gaixotasun batek azaltzen ez badu. Medikuntzako Akademia Nazionalaren esparruak 6 hilabete baino gehiagoko jarduera-murrizketa eskatzen du. NICEk gaixotasuna susmatzea aholkatzen du helduengan 6 asteren ondoren eta haur eta gazteengan 4 asteren ondoren. Ebaluazioak, laguntza praktikoak eta sintomak eragiten dituen gehiegizko esfortzua saihesteko aholkuak ez dute diagnostikoa berretsi arte itxaron behar.
POTS izateak esan nahi du ME/CFS dudala?
POTSak berez ez du ME/CFS diagnostikatzen, nahiz eta bi gaitzak batera ager daitezkeen. Helduen POTS irizpideen artean, zutik jarri eta 10 minuturen barruan bihotz-maiztasunak gutxienez 30 taupada/minutuko igoera iraunkorra izatea, gutxienez 3 hilabetez maiz ortostatismo-sintomak izatea eta beste azalpen batzuk baztertzea daude. 12–19 urtekoentzat bihotz-maiztasunaren atalasea gutxienez 40 taupada/minutukoa da. ME/CFS diagnostikatzeko, sintomak eta funtzionamendu-gaitasuna bereiz ebaluatu behar dira, ahaleginaren ondorengo ondoeza eta lo ez-berritzailea barne.
ME/CFSaren ebaluazioa egiteko zain nagoen bitartean, ariketa gehiago egin behar al dut?
Ez erabili ariketa-maila finkoen igoerarik susmatzen den esfortzu ondoko ondoeza gainditzeko. NICEk ME/CFSrako jarduera edo ariketa aurrez zehaztutako mailak pixkanaka handitzean oinarritutako programak ez ditu gomendatzen. Jarraitu jarduerak hurrengo 24–48 orduetan sintomei nola eragiten dien, eta hitz egin klinikari batekin energia kudeatzeko modu pertsonalizatuaz. Horrek ez du esan nahi denek mugimendu oro saihestu behar dutenik; pazienteen artean alde handiak daude jasan dezaketen jardueran eta behar duten laguntzan.
Burdin-gabeziak edo depresioak ME/CFS bazter dezakete?
0 Iron deficiency or depression does not automatically rule out ME/CFS, egoera bat baino gehiago egon baitaiteke. Ferritina 15 ng/mL-tik beherakoa izateak burdin-erreserbak agortuta daudela adierazten du sendo, bestela osasuntsu dauden helduengan, nahiz eta interpretazioa aldatu egiten den hanturaren eta beste egoera batzuen arabera. Klinikariek identifikatutako faktore lagungarriak tratatzen dituzte, eta berriz ebaluatzen dute ea sintomen eredu osoa azaltzen duten, esfortzuaren ondorengo ondoeza atzeratua barne. Tratamenduaren ondoren sintomek irauten badute, berrikuspen klinikoa behar da, eta ez pentsatzea diagnostikoetako batek dena azaltzen duela.
Lortu gaur AI bidezko odol-analisien analisia
Batu mundu osoko 2 milioi erabiltzaile baino gehiagok Kantesti-n konfiantza dutenak, laborategiko analisiak berehala eta zehaztasunez aztertzeko. Igo zure odol-analisien emaitzak eta jaso 15,000+ biomarkatzaileen interpretazio integrala segundo gutxitan.
📚 Erreferentziatutako ikerketa-argitalpenak
Klein, T., Mitchell, S., & Weber, H. (2026). C3 C4 Osagarriaren odol-analisia eta ANA tituluaren gida. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Nipah Birusaren Odol Azterketa: Detekzio Goiztiarra eta Diagnostiko Gida 2026. Kantesti AI Medical Research.
📖 Kanpoko erreferentzia medikoak
Osasun eta Arreta Bikaintasunaren Institutu Nazionala (NICE) (2021). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. NICE guideline NG206.
Institute of Medicine (2015). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press.
Raj SR, Fedorowski A, Sheldon RS (2022). Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ.
⚕️ Ohar medikoa
Artikulu hau hezkuntza-helburuetarako da soilik eta ez du mediku-aholkurik ematen. Diagnostiko- eta tratamendu-erabakietarako, beti kontsultatu osasun-profesional kualifikatu bati.
E-E-A-T Konfiantza-seinaleak
Esperientzia
Medikuek gidatutako berrikuspen klinikoa laborategiko interpretazioaren lan-fluxuei buruz.
Espezializazioa
Laborategiko medikuntzaren ikuspegia biomarkatzaileek testuinguru klinikoan nola jokatzen duten aztertzean.
Autoritatea
Dr. Thomas Klein-ek idatzia, eta Dr. Sarah Mitchell eta Prof. Dr. Hans Weber-ek berrikusia.
Fidagarritasuna
Ebidentzian oinarritutako interpretazioa, alarma murrizteko jarraipen-bide argiekin.